“3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES”. International Journal of Experimental Biology 2, no. 01 (June 30, 2024): 50–73. Accessed November 20, 2026. https://www.ijeb.online/index.php/IJEB/article/view/23.